Prevalence of metabolic syndrome among adults in a rural area

Iranian Journal of Endocrinology and Metabolism

Volumn 11, Issue 4, 2009, Pages

  Jalali, R ^a   Vasheghani, M ^a   Dabbaghmanesh, M H ^a   Ranjbar Omrani, Gh ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ATP III; IDF; Metabolic syndrom; Modified ATP III

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; EDUCATION; FEMALE; HUMAN; INTERVENTION STUDY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MARRIAGE; METABOLIC SYNDROME X; POPULATION; PREVALENCE; RURAL AREA; SEX DIFFERENCE; WEIGHT REDUCTION;

EID: 76049126908     PISSN: 16834844     EISSN: 16835476     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
2. Defronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hyper tension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
3. Haffner SM, Valder RA, Hazuda HP, Mitchell BD, Morals PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome x). Diabetes 1992; 41: 715-22.
4. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004 27;110:e35.
5. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-7.
6. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003; 26: 3153-9.
7. Wang JJ, Li HB, Kinnunen L, Hu G, Jarvinen TM, Miettinen ME, et al. How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population? Atherosclerosis 2007. 192: 161-8.
8. Wang JJ, Hu G, Miettinen ME, Tuomilehto J. The metabolic syndrome and incident diabetes: assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial glucose. Horm Metab Res 2004; 36: 708-15.
9. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16.
10. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164: 1066-76.
11. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28: 1769-78.
12. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49:403-14.
13. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Fedration among adults in the U.S. Diabetes Care 2005; 28: 2745 -9.
14. Third report of the National Cholesterol Education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106: 3143-421.
15. Grundy SM, Cleeman Jl, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006; 21: 1- 6.
16. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. A consensus statement from the international diabetes federation. Lancet 2005; 366: 1059-62.
17. Azizi F, Rahmani M, Emami H, Majidi M. Tehran lipid and glucose study: rationale and design, CVD prevention 2000; 3: 242 -7.
18. M.Gharipour, A. Boshtam. K.Rabiei. Prevalence of metabolic syndrome among the adults of central of areas of Iran. Elmi, J.Birjand University Medical Sciences 2006; 3: 56-63. [Farsi]
19. Harzallah F, Alberti H, Ben khalifa F. The metabolic syndrome an Arab population : a first look at the new international diabetes federation criteria. Diabetes Med 2006; 23: 441-4.
20. Ford S. Prevalence of the metabolic syndrome defined by the international diabetes federation a mong adults in the U.S. Diabetes care 2005; 28: 2745-9.
21. Velasquez-melendez G, Gazzinelli A, Correa-Oliveira R, marcal pimenta A, Kak G. Prevalence of metabolic syndrome in a rural area of Brazil. Sqo Paulo med J 2007; 125: 155-62.
22. Morimoto A, Nishimura R, Suzuki N, Matsudaira T, Taki K, Tsujino D, et al. Low prevalence of metabolic syndrome and its components in rural Japan. Thhoku J. EXP. Med 2008; 216: 69-75.
23. Janus ED, Laatikainen T, Dunbar JA, Kikkinen A, Bunker SJ, Philpot B, et al. overweight, obesity and metabolic syndrome in rural southeastern Australia. Med J Aust 2007; 187: 147-52.
24. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Eordon NH, Jervell J. The metabolic syndrome in west Bank population: and urban-rural omparison. Diabetes Care 2001: 275-9.
25. Azizi F, Salehl P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran. Diabetes Res Clin Pract 2003; 61: 29-32.
26. Malek M, Hadaegh F, Harati H, Azizi F. Prediction of cardiovascular disease by metabolic syndrome in individuals aged over 40 yrs according to the ATP III and IDF definition: Tehran Lipid and Glucose study. Iranian Journal Endocrinology and Metabolism 2006; 3 249 -57.
27. Kim ES, Han SM, Kim YI, Song K.H, Kim M.S, Kim W.B. prevalence and clinical characteristics of metabolic syndrome in a rural population of south korea. Diabet Med 2004; 21:1141-3.
28. Hildrum B, Mykeletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the international Diabetes federation and the National cholestrol Education program: the Norwegian HONT2 study BMC public Health 2007, 7: 220.
29. Ruderman N, Chisholm D, Pi-Sunver X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713.
30. Tanka S, Togashi K, Rankinen T, Perusse L, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C. Is adiposity at normal body weight relevant for cardiovascular disease risk? Int J Obes Relat Metab Disord 2002; 26: 176-83.
31. Al- Lawati JA, Mohammed AJ, AL-Hinai HQ, Jousilahti P.Prevalence of the metabolic syndrome among Omani addults. Diabetes Care 2003; 26: 1781-5.
32. Bucher KD, Friedlander Y, Kaplan EB, Namboodiri KK, Kark JD, Eisenberg S, Stein Y, Rifkind B.M. Biological and cultural sources of familial resemblance in plasma lipids: a comparison between North America and Israel-the Lipid Research Clinics, program. Genet Epidemiol 1988; 5: 17-33.
33. Austin MA, King MC, Bawol RD, Hulley SB, Friedman GD. Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences, Am J Epidemiol 1987; 125: 308-18.
34. Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 1993; 328: 1150-56.
35. Koizumi J, Inazu A, Yagi K, Koizumi I, Uno Y, Kajinami K, et al. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholestery ester transter protein deficiency. Atherosclerosis 1991; 90: 189-96.
36. Santamarina-Fojo S, Haudenschild C, Amar M. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr. Opin. Lipidol 1998; 9: 211-9.
37. Santos AC, Lopes C, Barros H. Prevalence of metabolic syndrome in the city of Porto. Rev port Cardiol 2004; 23: 45-52.